Article

In silico screening of indinavir-based compounds targeting proteolytic activity in HIV PR: binding pocket fit approach

2011-12-26

Abstract excerpt

No abstract is available from the source.

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 75d7a71c-8495-5808-a3a6-414a7b8c7c91
DOI: 10.1007/s00044-011-9941-5

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

In silico screening of indinavir-based compounds targeting proteolytic activity in HIV PR: binding pocket fit approachDOI 10.1007/s00044-011-9941-5Read

Current and Novel Inhibitors of HIV ProteaseSemantic proximity Read

Design of novel HIV-1 protease inhibitors with favorable oral properties using a virtual screening and lead optimization approachSemantic proximity Read

Identification of Structural Mechanisms of HIV-1 Protease Specificity Using Computational Peptide Docking: Implications for Drug ResistanceSemantic proximity Read

Molecular docking-based screening for novel inhibitors of the human immunodeficiency virus type 1 protease that effectively reduce the viral replication in human cellsSemantic proximity Read

Comprehending the Structure, Dynamics, and Mechanism of Action of Drug-Resistant HIV ProteaseSemantic proximity Read

Use of virtual screening for discovering antiretroviral compounds interacting with the HIV-1 nucleocapsid proteinSemantic proximity Read

A combinatorial library of indinavir analogues and its in vitro and in vivo studies.Semantic proximity Read

Dynamic receptor-based pharmacophore model development and its application in designing novel HIV-1 integrase inhibitors.Semantic proximity Read

An in silico pharmacological approach toward the discovery of potent inhibitors to combat drug resistance HIV‐1 protease variantsSemantic proximity Read

Design of mutation-resistant HIV protease inhibitors with the substrate envelope hypothesis.Semantic proximity Read

Taking aim at a moving target: designing drugs to inhibit drug-resistant HIV-1 reverse transcriptasesSemantic proximity Read

Discovery of Entry Inhibitors for HIV-1 via a New De Novo Protein Design FrameworkSemantic proximity Read